Claessen, Bimmer E <br/><br/>
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial.  [electronic resource] 

 -  Circulation. Cardiovascular interventions  Aug 2009 
 - 339-47 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1941-7632 
<br/><br/><label>Standard No.: </label>10.1161/CIRCINTERVENTIONS.108.831800.108.831800  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angioplasty, Balloon, Coronary--adverse effects<br/>Cardiovascular Agents--administration & dosage<br/>Coronary Angiography<br/>Coronary Artery Disease--diagnostic imaging<br/>Drug-Eluting Stents<br/>Europe<br/>Everolimus<br/>Female<br/>Humans<br/>India<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--diagnostic imaging<br/>Myocardial Ischemia--diagnostic imaging<br/>New Zealand<br/>Paclitaxel--administration & dosage<br/>Prospective Studies<br/>Single-Blind Method<br/>Sirolimus--administration & dosage<br/>Thrombosis--diagnostic imaging<br/>Time Factors<br/>Treatment Outcome<br/>Ultrasonography, Interventional